About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Updated Non-Confidential Presentation CEO USA Roadshow

August 13, 2018

Click here to read more

Post navigation

Newsletter – August 2018

Phosphagenics Receives Arbitration Update from SIAC

Related Posts

New Product License and Supply Agreement for US recreational cannabis market

February 2, 2022February 2, 2022

Phosphagenics Expands License Agreement for Diclofenac Gel

May 18, 2016

AGM Chairman and CEO Addresses

May 31, 2017

Recent Posts

Media Coverage | Nine News
October 21, 2024
First Patient Dosed in Phase III Insomnia Trial
May 16, 2024
MEDIA | Channel 9 News
March 28, 2024

Categories

Analyst Coverage
Company Announcement
Company Report
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.